Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
Read CEO David Rosén’s interview with Dagens industri (in Swedish).
A3P in media
Finally time for public screening of prostate cancer? (In Swedish)
November 22, 2021. Stockholm3 together with MRI make public screening possible. The scientific leader of the STHLM3MR study, Dr Tobias Nordström, is interviewed by Prostate News. Prostate News is published by the Swedish prostate cancer patient organization. Click here to read the full interview with Dr Tobias Nordström
Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
Professor Henrik Grönberg presents how Stockholm3, in combination with MRI, make general screening of prostate cancer possible. Oktober 6, 2021. Dagens Medicin Cancerdagen
Latest news: New method effective for detecting prostate cancer (in Swedish)
The results of the STHLM3 MRI trial is now published in the scientific publication The Lancet Oncology. Tobias Nordström, urologist, talks about the strong results.
Salming and Sauk about prostate cancer and the importance of taking a test (in Swedish)
Börje Salming and Stefan Sauk urges all men to get tested for prostate cancer. For Sauk’s part, the Stockholm3 test was crucial in finding his cancer early.
The truth about my prostate cancer (in Swedish)
Henrik Grönberg and actor Stefan Sauk about prostate cancer and the Stockholm3 test.
Swedish actor Stefan Sauk – early detection is the key (in Swedish)
When you get symptoms it is no longer early. Late detection and cancer is a very bad combination. Stefan Sauk about the Stockholm3 test that found his prostate cancer on an early stage).
From prostate cancer to COVID – EIT Health interview with Martin Steinberg
Without slowing down in prostate cancer diagnostics, A3P Biomedical has also supported the Swedish Public Health Agency in analyzing over 180,000 PCR tests for Covid-19 in 2020.
“New prostate cancer test could save thousands of lives”
“Across Europe there is an urgent need to refocus attention on prostate cancer diagnosis, as despite being the most common form of cancer for men in Europe, there is still an alarming lack of awareness around the disease.” The Brussel Times interviews Martin Steinberg, A3P Biomedical AB, about the blood test Stockholm3.
Henrik Grönberg talks about Stockholm3 on national radio (in Swedish)
Prostate cancer is a disease that gives no symptoms and the only way to find it early is by taking a blood sample. This is what professor and chief physician Henrik Grönberg says in an interview with Swedish Radio about prostate cancer diagnostics and Stockholm3. Henrik Grönberg is part of the team that developed the blood sample…
A3P Biomedical deepens cooperation with Mehiläinen – Finland’s largest private healthcare provider
Mehiläinen and A3P Biomedical’s lab have a long-standing collaboration on prostate cancer diagnostics with the new Stockholm3 test. In 2020, the collaboration will be expanded to also apply analysis of PCR tests for Covid-19.
Capio podd: Henrik Grönberg talks about prostate cancer and Stockholm3 (in Swedish)
Henrik Grönberg is a specialist in oncology and professor of cancer epidemiology. He works as chief physician and head of Prostatacancercentrum at Capio St. Göran’s Hospital in Stockholm. In the podcast, he talks about prostate cancer diagnostics and the new Stockholm3 test.
Find more cases of aggressive prostate cancer. Henrik Grönberg’s interview with the Swedish Cancer Society (in Swedish)
“If I have to pick a single moment from the 25 years I have been researching about prostate cancer, it would be when our article on the research project STHLM3 was accepted in the scientific journal The Lancet Oncology 2015.” Professor Henrik Grönberg researches to improve prostate cancer diagnostics. In an interview with the Swedish…
Fastleger in Rogaland, Norway replace PSA with a new cancer marker (in Norwegian)
“As far as we know, no other test achieves the same sensitivity and specificity as Stockholm3. I therefore believe that Stockholm3 will be the new standard and that it will change clinical practice in Scandinavia and in most high-income countries because the diagnostics will be profoundly better.”, says Sven R Kjosavik, doctor in the…
New method gives more certain results for prostate cancer (in Swedish)
In an interview with the Swedish journal Onkologi, chief physician Tobias Nordström talks about the successful research project STHLM3-MR. In the study, Tobias Nordström and his colleagues investigate whether examination with the blood test Stockholm3 in combination with magnetic resonance imaging can improve prostate cancer…
EIT Health takes three of four EIT Awards
A3P Biomedical receives the EIT Innovators Award 2019 for Stockholm3, with the motivation: “The winner demonstrated uniqueness and originality of the product, and clearly addresses a market need in the medical field that potentially affects millions of individuals. The innovation has been tested and validated, and the expected societal…
New method provides more accurate prostate test (in Swedish)
Prostatacancercentrum at Capio St. Göran’s Hospital in Stockholm uses a new method that greatly improves prostate cancer diagnostics. The method combines the blood test Stockholm3 with targeted tissue samples.
A combination of tests can improve prostate cancer diagnostics (in Swedish)
A combination of tests can improve prostate cancer diagnostics. A new paper from Karolinska Institutet shows that the Stockholm3 blood test in combination with MRI and targeted tissue samples provides better prostate cancer diagnostics. The number of unnecessary biopsies and diagnoses of harmless cancer is greatly reduced. At the same…